Swiss Biotech financings were weaker in 2012 with only USD 117 M being raised. In the same period the number of companies increased by 9% – primarily companies in therapeutics and R&D services.
Click here to download Swiss Life Sciences Trend Analysis 2013 – 12 pages
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.